Gastrinomas: comparison of MR imaging with CT, angiography, and US
- PMID: 2655004
- DOI: 10.1148/radiology.171.3.2655004
Gastrinomas: comparison of MR imaging with CT, angiography, and US
Abstract
In this prospective study, magnetic resonance (MR) imaging was used to localize gastrinoma in 24 patients with Zollinger-Ellison syndrome. The results were confirmed by means of either surgery or percutaneous liver biopsy and compared with results of computed tomographic (CT) scanning, selective abdominal angiography, and abdominal ultrasound (US). For primary extrahepatic gastrinoma (intra-or extrapancreatic), MR imaging had a sensitivity of 20% and a specificity of 100%, with a positive predictive value of 100% and a negative predictive value of 11%. For metastatic gastrinoma in the liver, MR imaging had a sensitivity of 43% and a specificity of 100%, with a positive predictive value of 100% and a negative predictive value of 81%. The ability of MR imaging to depict extrahepatic gastrinomas was directly related to tumor size; no tumors smaller than 1 cm were detected, and 50% of tumors 3 cm or larger were detected. MR imaging was as effective as abdominal US but less effective than either CT scanning or selective abdominal angiography for the detection of extrahepatic gastrinoma. In seven patients with hepatic gastrinoma, three gastrinomas were detected with MR imaging and with abdominal US, while five were detected with CT scanning and with selective abdominal angiography. These results indicate that, at the present time, MR imaging is generally not useful in the initial attempt to localize gastrinomas.
Similar articles
-
Zollinger-Ellison syndrome: prospective assessment of abdominal US in the localization of gastrinomas.Radiology. 1991 Mar;178(3):763-7. doi: 10.1148/radiology.178.3.1994415. Radiology. 1991. PMID: 1994415 Clinical Trial.
-
Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome.Gastroenterology. 1987 Apr;92(4):905-12. doi: 10.1016/0016-5085(87)90963-2. Gastroenterology. 1987. PMID: 3556996
-
Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome.Dig Dis Sci. 1993 Jul;38(7):1318-28. doi: 10.1007/BF01296084. Dig Dis Sci. 1993. PMID: 8325191 Free PMC article.
-
Gastrinoma: sporadic and familial disease.Surg Oncol Clin N Am. 2006 Jul;15(3):479-96. doi: 10.1016/j.soc.2006.05.001. Surg Oncol Clin N Am. 2006. PMID: 16882493 Review.
-
Zollinger-Ellison syndrome. Recent advances in the management of the gastrinoma.Gastroenterol Clin North Am. 1990 Mar;19(1):197-217. Gastroenterol Clin North Am. 1990. PMID: 2184129 Review.
Cited by
-
Functional, Diagnostic and Therapeutic Aspects of Gastrointestinal Hormones.Gastroenterology Res. 2019 Oct;12(5):233-244. doi: 10.14740/gr1219. Epub 2019 Oct 4. Gastroenterology Res. 2019. PMID: 31636773 Free PMC article. Review.
-
Carcinoid tumors of the pancreas: CT findings.Abdom Imaging. 1994 May-Jun;19(3):221-4. doi: 10.1007/BF00203511. Abdom Imaging. 1994. PMID: 8019347
-
Current Management of Neuroendocrine Tumour Liver Metastases.Curr Oncol Rep. 2024 Sep;26(9):1070-1084. doi: 10.1007/s11912-024-01559-w. Epub 2024 Jun 13. Curr Oncol Rep. 2024. PMID: 38869667 Free PMC article. Review.
-
Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study.Ann Surg. 1992 Jan;215(1):8-18. doi: 10.1097/00000658-199201000-00012. Ann Surg. 1992. PMID: 1531004 Free PMC article. Clinical Trial.
-
Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies.Cancers (Basel). 2022 Feb 28;14(5):1250. doi: 10.3390/cancers14051250. Cancers (Basel). 2022. PMID: 35267558 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical